研究人类大脑中的类似葡萄糖-1及其受体:表达的分布,功能影响,与年龄相关的变化和物种特定特征
Tulika Gupta1, Mandeep Kaur1, Devendra Shekhawat1
1Department of Anatomy, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Basic and clinical neuroscience
|December 11, 2023
概括
类似葡萄糖-1 (GLP-1) 在大多数人类大脑区域中发现,但随着年龄的增长而下降,特别是在50岁以后. 这种GLP-1及其受体 (GLP-1R) 的映射可能会揭示新的阿尔茨海默病治疗方法.
科学领域:
- 神经科学是一个神经科学.
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 葡萄糖类-1 (GLP-1) 激动剂在阿尔茨海默氏症治疗方面表现有前途.
- 人类大脑中GLP-1的神经点和分布尚不清楚.
研究的目的:
- 在人类大脑中进行GLP-1及其受体 (GLP-1R) 的全脑映射.
- 为了确定GLP-1在阿尔茨海默病中的治疗效果的潜在神经基质.
主要方法:
- 在30个人类大脑中全脑映射GLP-1和GLP-1R分布.
- GLP-1表达的分析使用免疫组织化学和西方布洛特.
- 通过逆转录聚合酶链反应 (RT-PCR) 研究GLP-1R基因表达.
主要成果:
- 观察到GLP-1的表达在皮质区域 (额头,前额头,头顶),二脑和脑干,但不是小脑.
- 在前皮层发现GLP-1R的最高表达;在轨道前皮层和小脑中可以忽略不计.
- 在海马体有显著的GLP-1R存在,GLP-1免疫活性不齐;GLP-1在第五个十年后与年龄相关的衰退.
结论:
- 人类大脑GLP-1R的分布与动物模型不同,尤其是它在小脑中不存在.
- 确定GLP-1水平与年龄相关的下降,特别是在50岁后的皮质区域.
- 这种全面的映射提供了关于GLP-1在大脑中的作用和新型阿尔茨海默病治疗的潜力.
相关概念视频
Glucagon-like Receptor Agonists
327
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
327
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.3K
Hypoglycemia and Glucagon
266
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
266
Regulation of Food Intake
239
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
239
Hormones Regulating Blood Glucose
3.4K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.4K


